NSPR InspireMD, Inc.

BULLISH Impact: 5/10 Insider Cluster (3 insiders)
Horizon days Filed May 7, 2026 Processed 1mo ago
Insider cluster: 3 insiders, $0.3M total
Latest settled — T+20d
NSPR ▼ -17.24% at T+20d
LONG call ✗ call lost -17.24% · α vs SPY -20.38% · entry $1.16 → $0.9600
Next anchor: T+60d in 7w
Last close $0.7300 (close Jun 12) · -37.07% from $1.16 entry
Entry anchored
May 6, 03:59 PM ET
via Databento tick
T+1d
-0.86%
call -0.86% · α -1.69%
$1.15
settled 6w ago
T+5d
+0.86%
call +0.86% · α -0.64%
$1.17
settled 5w ago
T+20d
-17.24%
call -17.24% · α -20.38%
$0.9600
settled 11d ago
T+60d
call — · α —
in 7w

Price Chart

Loading chart...

Executive Summary

Three directors at InspireMD (NSPR) purchased a total of $267K in open-market shares over the past week, representing 0.45% of market cap. This follows a strong Q1 earnings report with 122% revenue growth, but also a voluntary product recall and widening net losses, suggesting a mixed outlook but insider confidence.

Key Financial Metrics

Direction
buying
Total Value
$267.0K
Insiders
3

Actionable Insight

The unanimous director buying after strong revenue growth suggests confidence in the long-term story despite short-term recall headwinds. Watch for follow-on C-suite purchases or further disclosures on FDA milestones (CGuard approval, CGUARDIANS III trial). The cluster size is modest relative to market cap, so it's a supportive signal but not a standalone catalyst.

Key Facts

  • Three directors (Roubin, Ward, Stuka) purchased shares totaling $267K at prices $1.12-$1.19
  • Purchases represent 0.45% of $59M market cap — modest but notable
  • Q1 2026 revenue grew 122% YoY to $3.4M; net loss widened to $13.7M
  • Voluntary recall of CGuard Prime 135 cm with estimated $1.35M in costs
  • No C-suite insider buying in this cluster

Financial Impact

$267,000 in open-market purchases by directors

insider confidence signal

Risk Factors

  • Voluntary recall may pressure near-term sales and margins
  • Net losses continue to widen despite revenue growth
  • Low market cap and liquidity could amplify volatility

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
89% bullish (9 analysts)

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-NSPR-1778628994544
11 reports for NSPR
Performance horizon
80% Hit rate 4 of 5 directional calls best @ T+20▲ +21.48%Apr 3, 2026
Filters
Rows
Reports for NSPR — sortable, filterable
Type Now
May 21, 2026
24d ago
Insider Cluster
NEUTRAL ★ 4/10
$1.00 $0.9900▼ −1.00%▼ −2.66%$0.7300 (−27.00%)
May 15, 2026
4w ago
Insider Cluster
BULLISH ★ 6/10
$1.05 $0.9500▼ −9.52%▼ −11.14%$0.7300 (−30.48%)
May 7, 2026
5w ago
Insider Cluster
BULLISH ★ 5/10
$1.16 $1.17▲ +0.86%▼ −0.64%$0.7300 (−37.07%)
May 1, 2026
6w ago
8-K
BEARISH ★ 7/10
$1.17 $1.25▼ −6.84%▼ −3.90%$0.7300 (+37.61%)
May 1, 2026
6w ago
Press Release
BEARISH ★ 7/10
$1.17 $1.25▼ −6.84%▼ −3.90%$0.7300 (+37.61%)
May 1, 2026
6w ago
Press Release
BULLISH ★ 6/10
$1.17 $1.25▲ +6.84%▲ +3.90%$0.7300 (−37.61%)
Apr 22, 2026
7w ago
DEFA14A
NEUTRAL ★ 4/10
$1.28 $1.14▼ −10.94%▼ −12.42%$0.7300 (−42.97%)
Apr 20, 2026
7w ago
DEFA14A
NEUTRAL ★ 3/10
$1.33 $1.14▼ −14.29%▼ −15.37%$0.7300 (−45.11%)
Apr 3, 2026
10w ago
424B5
BEARISH ★ 6/10
$1.49 $1.35▲ +9.40%▲ +13.53%$0.7300 (+51.01%)
Mar 18, 2026
12w ago
8-K
NEUTRAL ★ 4/10
$1.79 $1.77▼ −1.12%▼ −0.40%$0.7300 (−59.22%)
Showing 10 of 11

US Market Status

Market Closed — Opens in 5h 10m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access